Modeling manufacturer cost-sharing under Part D shake-up 

If changes to Medicare Part D in the Build Back Better bill become law, manufacturers of specialty medicines could see their cost-sharing under Medicare Part D increase by a factor of 10 or more, according to an analysis by BioCentury. 

Part D helps Medicare beneficiaries pay for self-administered prescription drugs by splitting the cost of the therapies between Medicare, the patient, drug manufacturers and patient plans. Build Back Better would change how much each entity pays in each of Part D’s different coverage phases...